| Literature DB >> 21547255 |
Qun Zhang1, Jian-Chun Yu, Wei-Ming Kang, Guang-Jin Zhu.
Abstract
OBJECTIVE: To investigate whether ω-3 fatty acid could stimulate gastrointestinal motility after abdominal operation.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21547255 PMCID: PMC3086275 DOI: 10.1155/2011/152137
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Gastric emptying rate (%).
| POD1 | POD3 | POD6 | |
|---|---|---|---|
| (1) normal saline group ( | 24.70 ± 2.73 | 34.82 ± 3.02 | 46.48 ± 3.25 |
| (2) intralipid group ( | 24.58 ± 2.54 | 37.32 ± 2.01 | 47.90 ± 2.21 |
| (3) | 24.62 ± 2.32 | 40.35 ± 1.9 | 347.33 ± 4.03 |
|
| 0.959 | 0.004* | 0.740 |
|
| 0.974 | 0.044* | 0.820 |
|
| 0.935 | 0.095 | 0.401 |
Small bowel propulsion rate (%).
| POD1 | POD3 | POD6 | |
|---|---|---|---|
| (1) Normal saline group ( | 35.27 ± 3.09 | 40.48 ± 2.71 | 53.93 ± 2.49 |
| (2) Intralipid group ( | 35.35 ± 3.76 | 43.12 ± 2.34 | 55.32 ± 3.23 |
| (3) | 35.33 ± 2.87 | 48.58 ± 3.18 | 56.80 ± 2.19 |
|
| 0.972 | 0.002* | 0.164 |
|
| 0.992 | 0.008* | 0.458 |
|
| 0.975 | 0.147 | 0.935 |
Serum GAS (pg/mL).
| POD1 | POD3 | POD6 | |
|---|---|---|---|
| (1) normal saline group ( | 93.78 ± 19.21 | 122.25 ± 18.78 | 153.58 ± 26.74 |
| (2) intralipid group ( | 92.00 ± 12.13 | 150.75 ± 20.301 | 51.55 ± 26.27 |
| (3) | 94.67 ± 17.46 | 156.68 ± 22.10 | 154.23 ± 20.93 |
|
| 0.849 | 0.002* | 0.968 |
|
| 0.517 | 0.287 | 0.870 |
|
| 0.574 | 0.001* | 0.900 |
MTL (pg/mL).
| POD1 | POD3 | POD6 | |
|---|---|---|---|
| (1) normal saline group ( | 137.83 ± 17.34 | 185.25 ± 16.27 | 234.22 ± 24.68 |
| (2) intralipid group ( | 147.65 ± 15.29 | 227.62 ± 23.58 | 233.98 ± 24.31 |
| (3) | 140.10 ± 20.48 | 225.45 ± 20.20 | 238.12 ± 24.81 |
|
| 0.881 | 0.002* | 0.835 |
|
| 0.301 | 0.880 | 0.561 |
|
| 0.384 | 0.029* | 0.989 |
IL-1 (pg/mL).
| POD1 | POD3 | POD6 | |
|---|---|---|---|
| (1) normal saline group ( | 75.92 ± 8.40 | 71.30 ± 4.76 | 54.45 ± 6.18 |
| (2) intralipid group ( | 77.15 ± 4.31 | 68.72 ± 4.15 | 53.45 ± 4.76 |
| (3) | 74.80 ± 5.28 | 60.23 ± 5.51 | 54.28 ± 3.95 |
|
| 0.683 | 0.007* | 0.941 |
|
| 0.366 | 0.004* | 0.568 |
|
| 0.642 | 0.194 | 0.549 |
IL-6 (pg/mL).
| POD1 | POD3 | POD6 | |
|---|---|---|---|
| (1) normal saline group ( | 201.70 ± 22.58 | 217.97 ± 32.631 | 43.70 ± 30.79 |
| (2) intralipid group ( | 215.83 ± 32.48 | 216.63 ± 27.96 | 127.83 ± 14.08 |
| (3) | 207.83 ± 16.62 | 173.98 ± 12.76 | 142.22 ± 20.64 |
|
| 0.545 | 0.015* | 0.907 |
|
| 0.519 | 0.011* | 0.216 |
|
| 0.325 | 0.672 | 0.347 |
TNF-α (pg/mL).
| POD1 | POD3 | POD6 | |
|---|---|---|---|
| (1) normal saline group ( | 15.03 ± 2.02 | 13.97 ± 1.86 | 9.75 ± 1.58 |
| (2) intralipid group ( | 15.57 ± 1.77 | 14.83 ± 1.65 | 10.70 ± 2.34 |
| (3) | 14.00 ± 3.07 | 12.50 ± 1.70 | 9.87 ± 1.43 |
|
| 0.439 | 0.007* | 0.871 |
|
| 0.251 | 0.015* | 0.255 |
|
| 0.603 | 0.672 | 0.347 |
COX-2 (ng/mL).
| POD1 | POD3 | POD6 | |
|---|---|---|---|
| (1) normal saline group ( | 15.03 ± 2.02 | 13.97 ± 1.86 | 9.75 ± 1.58 |
| (2) intralipid group ( | 15.57 ± 1.77 | 14.83 ± 1.65 | 10.70 ± 2.34 |
| (3) | 14.00 ± 3.07 | 12.50 ± 1.70 | 9.87 ± 1.43 |
|
| 0.439 | 0.007* | 0.871 |
|
| 0.251 | 0.015* | 0.255 |
|
| 0.603 | 0.672 | 0.347 |